Creative Planning’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Creative Planning’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,000	Closed	-$64K	–	5052
2016 Q3	$64K	Buy	17,000 +2,000	+13%	+$9.11K	﹤0.01%	2170
2016 Q2	$78K	Hold	15,000	–	–	﹤0.01%	1834
2016 Q1	$71K	Hold	15,000	–	–	﹤0.01%	1856
2015 Q4	$70K	Hold	15,000	–	–	﹤0.01%	1855
2015 Q3	$56K	Buy	+15,000	New	+$104K	﹤0.01%	1967

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Creative Planning's CPHR Position: Q4 2016 in Review

Creative Planning sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 17,000 shares — an estimated $64K sold.

Creative Planning first reported a position in CPHR in Q3 2015 and held it in 5 quarters. The position peaked at $78K in Q2 2016. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Creative Planning reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Creative Planning sold 17,000 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $64K.
Creative Planning first reported a position in Cipher Pharmaceuticals Inc. in Q3 2015 and held it in 5 quarters.
Creative Planning's Cipher Pharmaceuticals Inc. position peaked at $78K in Q2 2016.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.